Bioequivalence, Therapeutic Equivalence, & Clinical Case Management in Thyroid Disease
Studies consistently show that as many as 40% of patients with hypo- or hyper-thyroidism are not well managed by physicians. These studies each used thyroid-stimulating hormone (TSH) as the clinical marker of thyroid dysfunction.
This program is supported by an educational grant from Abbott Laboratories.

Talking to Your Patients About Their Third Party Co-Pays
This program will outline how to train an on-staff,
third party specialist and capitalize on the independent
pharmacy's unique ability to proactively address third party
issues with patients. The result-patients get the best value
for their dollar and the pharmacy.
This program is supported by an educational grant from Merck & Co., Inc.

The Role of Pharmaceuticals in Reducing Cardiometabolic Risk: Rethinking Pharmacy Benefit Design to Reduce the Burden on the Healthcare System
It is estimated that approximately 20-25 percent of the adult population has metabolic syndrome. Cardiovascular disease, the number one killer of people with metabolic syndrome and the leading cause of death in the US, is associated with nearly $400 billion in direct and indirect costs.
This program is supported through an educational grant from Sanofi Aventis.

Motion Sickness: Review of Preventative Remedies
Motion sickness arises when the brain receives conflicting signals from sensory organs about the body's orientation. Almost everyone will develop motion sickness symptoms if exposed to sufficiently violent movements. It is important for pharmacists to become familiar with the effective prescription and non-prescription treatments available to prevent its symptoms.
This program is supported by an educational grant from Hope Pharmaceuticals.